In one paragraphArticle in NAR cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Dorthy FangDepartment of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT 06511, United States.
Nicole S HarryDepartment of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT 06511, United States.
Renee PascoeDepartment of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT 06511, United States.
Je Won YangDepartment of Genetics, Yale School of Medicine, New Haven, CT 06510, United States.
Clara D WangDepartment of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT 06511, United States.
Funding
PREDOCTORAL TRAINING PROGRAM IN GENETICST32GM007499 · NIGMS · YALE UNIVERSITY · PI CARLSON, JOHN R, REINKE, VALERIE J · 1985 to 2022
$13.9MHigh-throughput detection of transcriptomic and epitranscriptomic variation and kinetics using MarathonRTR01HG011868 · NHGRI · YALE UNIVERSITY · PI GRAVELEY, BRENTON R., PYLE, ANNA MARIE · 2021 to 2024
$3.9MPredoctoral Program in Cellular, Molecular and Quantitative Biology (CMQBTP)T32GM145469 · NIGMS · YALE UNIVERSITY · PI Susan J Baserga, Charles Patrick Lusk · 2023 to 2026
$2.2MUncovering the regulatory principles of dynamic mRNA methylationR35GM146919 · NIGMS · YALE UNIVERSITY · PI Sigrid H Nachtergaele · 2022 to 2026
$2.0MHigh Performance Computing Instrumentation for the Yale Center for Genome AnalysisS10OD030363 · OD · YALE UNIVERSITY · PI MANE, SHRIKANT M · 2022 to 2022
$1.2MInvestigating the role of N6-methyladenosine in the development of drug resistance in glioblastomaF31CA306101 · NCI · YALE UNIVERSITY · PI Emily Dangelmaier · 2025 to 2026
$100kNCI NIH HHS F31 CA306101NHGRI NIH HHS R01 HG011868NIGMS NIH HHS R35 GM146919NIGMS NIH HHS T32 GM007499NIGMS NIH HHS T32 GM145469NIH HHS S10 OD030363
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
AdenosineBrain NeoplasmsDrug Resistance, NeoplasmGlioblastomaRNA, MessengerRNA StabilityTemozolomideAntineoplastic Agents, AlkylatingCell Line, TumorEpitranscriptomeGene Expression Regulation, NeoplasticHumansMethyltransferasesRNA MethylationAdenosineAntineoplastic Agents, AlkylatingMethyltransferasesMETTL3 protein, humanN-methyladenosineRNA, MessengerTemozolomide
Identifiers
PMID42818960
PMCPMC13624510
What OpenQuestion holds
Textmetadata
Read underepoch 390